Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

2210 - Genetic Association of Matrix metalloproteinase MMP- 1, MMP-3 and MMP-9 Genes with HCV-related Hepatocellular Carcinoma in Egyptian patients

Date

11 Sep 2017

Session

Poster display session

Topics

Translational Research;  Hepatobiliary Cancers

Presenters

Alshimaa Alhanafy

Citation

Annals of Oncology (2017) 28 (suppl_5): v595-v604. 10.1093/annonc/mdx391

Authors

A.M. Alhanafy1, B. Montaser2, W. Fathy2, N.S. Elabd3, S. Tayel4

Author affiliations

  • 1 Department Of Clinical Oncology And Nuclear Medicine, menoufia university, faculty of medicine, 32511 - Shebin El kom/EG
  • 2 Department Of Clinical Pathology, menoufia university, faculty of medicine, 32511 - sheben elkom/EG
  • 3 Department Of Tropical Medicine, menoufia university, faculty of medicine, 32511 - sheben elkom/EG
  • 4 Department Of Medical Biochemistry, menoufia university, faculty of medicine, 32511 - sheben elkom/EG
More

Resources

Abstract 2210

Background

Hepatocellular Carcinoma (HCC) is one of the most frequent cancers in Egypt where there is high prevalence of infection with the Hepatitis C virus (HCV). Matrix metalloproteinases (MMPs) are multifunctional proteins that play an important role in cell development, differentiation, inflammation and angiogenesis. Polymorphisms in MMPs genes might be involved in development of HCV related HCC. The aim of this study was to explore the relationship of gene polymorphisms in MMP-1,3 & 9 with liver cirrhosis and HCC patients.

Methods

The study included 128 subjects enrolled from Menoufia University Hospital inpatients and outpatients clinics from the Department of Clinical Oncology & Nuclear Medicine and Department of Tropical Medicine in the period between October 2015 and August 2016. Patients were classified into three groups. Group I: 48 patients with HCC in addition to liver cirrhosis, including 26 males and 22 females with a mean age of 58.60±5.29; Group II: 50 patients with liver cirrhosis, including 26 males and 24 females with a mean age of 56.74±5.21; Group III: 30 healthy subjects as controls, including 15 males and 15 females with a mean age of 56.30 ±7.30. Diagnosis of HCC was performed using two imaging methods (abdominal US & triphasic CT). All subjects except controls were positive for serum HCV RNA. Liver function tests, AFP & CHILD score were assessed. Gene polymorphisms were analysed using PCR-RFLP.

Results

HCC patients had higher mutant G2G2 (35.4%) and G2 allele (62.5%) of the MMP-1 gene than patients in both cirrhotic (P 

Conclusions

Gene mutations in MMP-1,3, 9 may be involved in progression of liver cirrhosis and risk relationship for HCC development.

Clinical trial identification

Legal entity responsible for the study

Menoufia University

Funding

None

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.